BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20608738)

  • 1. ATPases as drug targets: insights from heat shock proteins 70 and 90.
    Massey AJ
    J Med Chem; 2010 Oct; 53(20):7280-6. PubMed ID: 20608738
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular mechanism of Hsp70 chaperones].
    Mayer MP; Tomoyasu T; Bukau B
    Tanpakushitsu Kakusan Koso; 2002 Jul; 47(9):1189-95. PubMed ID: 12166065
    [No Abstract]   [Full Text] [Related]  

  • 3. Hsp70 and Hsp90--a relay team for protein folding.
    Wegele H; Müller L; Buchner J
    Rev Physiol Biochem Pharmacol; 2004; 151():1-44. PubMed ID: 14740253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of benzisoxazoles as potent inhibitors of chaperone heat shock protein 90.
    Gopalsamy A; Shi M; Golas J; Vogan E; Jacob J; Johnson M; Lee F; Nilakantan R; Petersen R; Svenson K; Chopra R; Tam MS; Wen Y; Ellingboe J; Arndt K; Boschelli F
    J Med Chem; 2008 Feb; 51(3):373-5. PubMed ID: 18197612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein 90 regulates development in Dictyostelium discoideum.
    Sawarkar R; Roy N; Rao S; Raman S; Venketesh S; Suguna K; Tatu U
    J Mol Biol; 2008 Oct; 383(1):24-35. PubMed ID: 18718841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Grp on the Hsp90 mechanism.
    Richter K; Reinstein J; Buchner J
    Mol Cell; 2007 Oct; 28(2):177-9. PubMed ID: 17964255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of ligand and structure-based virtual screening for the identification of the first dual targeting agent for heat shock protein 90 (Hsp90) and tubulin.
    Knox AJ; Price T; Pawlak M; Golfis G; Flood CT; Fayne D; Williams DC; Meegan MJ; Lloyd DG
    J Med Chem; 2009 Apr; 52(8):2177-80. PubMed ID: 19331414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
    Chiosis G; Caldas Lopes E; Solit D
    Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hop: more than an Hsp70/Hsp90 adaptor protein.
    Odunuga OO; Longshaw VM; Blatch GL
    Bioessays; 2004 Oct; 26(10):1058-68. PubMed ID: 15382137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HSP70: a challenging anti-cancer strategy.
    Goloudina AR; Demidov ON; Garrido C
    Cancer Lett; 2012 Dec; 325(2):117-24. PubMed ID: 22750096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90: chaperoning signal transduction.
    Richter K; Buchner J
    J Cell Physiol; 2001 Sep; 188(3):281-90. PubMed ID: 11473354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the function of Hsp70 chaperones.
    Zylicz M; Wawrzynow A
    IUBMB Life; 2001 May; 51(5):283-7. PubMed ID: 11699872
    [No Abstract]   [Full Text] [Related]  

  • 14. Constantly updated knowledge of Hsp90.
    Terasawa K; Minami M; Minami Y
    J Biochem; 2005 Apr; 137(4):443-7. PubMed ID: 15858167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system.
    Stahl M; Retzlaff M; Nassal M; Beck J
    Nucleic Acids Res; 2007; 35(18):6124-36. PubMed ID: 17804463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding.
    Freeman BC; Morimoto RI
    EMBO J; 1996 Jun; 15(12):2969-79. PubMed ID: 8670798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
    Kamal A; Thao L; Sensintaffar J; Zhang L; Boehm MF; Fritz LC; Burrows FJ
    Nature; 2003 Sep; 425(6956):407-10. PubMed ID: 14508491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox.
    Okada M; Itoh H; Hatakeyama T; Tokumitsu H; Kobayashi R
    Biochem J; 2003 Sep; 374(Pt 2):433-41. PubMed ID: 12803546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of benzamide tetrahydro-4H-carbazol-4-ones as novel small molecule inhibitors of Hsp90.
    Barta TE; Veal JM; Rice JW; Partridge JM; Fadden RP; Ma W; Jenks M; Geng L; Hanson GJ; Huang KH; Barabasz AF; Foley BE; Otto J; Hall SE
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3517-21. PubMed ID: 18511277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine-derived inhibitors of 78 kDa glucose regulated protein (Grp78) ATPase: insights into isoform selectivity.
    Macias AT; Williamson DS; Allen N; Borgognoni J; Clay A; Daniels Z; Dokurno P; Drysdale MJ; Francis GL; Graham CJ; Howes R; Matassova N; Murray JB; Parsons R; Shaw T; Surgenor AE; Terry L; Wang Y; Wood M; Massey AJ
    J Med Chem; 2011 Jun; 54(12):4034-41. PubMed ID: 21526763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.